About
Small Molecule for Hematologic Malignancies
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
430
By Phase
PHASE1: 5
By Status
RECRUITING: 3COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06708897Lead Sponsor
A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas
PHASE1Recruiting
66 participants
Started: Apr 8, 2025 · Completed: Apr 30, 2028
NCT06366789Lead Sponsor
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Recruiting
60 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
NCT06787131Lead Sponsor
Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
PHASE1Completed
104 participants
Started: May 21, 2024 · Completed: Jul 4, 2025
NCT06780124Lead Sponsor
Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers
PHASE1Recruiting
88 participants
Started: Apr 12, 2024 · Completed: Jun 30, 2025
NCT06399315Lead Sponsor
Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers
PHASE1Active, not recruiting
112 participants
Started: Jul 28, 2023 · Completed: Oct 30, 2025
Locations (1)
Headquarters
Dover, DE, United States
Map
Loading map...